The largest database of trusted experimental protocols
> Living Beings > Bacterium > Nontuberculous Mycobacteria

Nontuberculous Mycobacteria

Nontuberculous Mycobacteria (NTM) are a group of bacteria that can cause serious infections, but are not related to Tuberculosis.
These mycobacteria are found in the environment and can infect humans through exposure to contaminated water or soil.
NTM infections can be difficult to diagnose and treat, making research into effective diagnostic methods and treatment protocols crucial.
PubCompare.ai helps researchers optimize their NTM studies by surfacing the best protocols from published literature, preprints, and patents.
Its AI-driven comparisons enhance reproducibility and accuracy, enabling researchers to identify the most effective NTM research methods and products.
Explore the power of PubCompare.ai to take your NTM research to the next levle.

Most cited protocols related to «Nontuberculous Mycobacteria»

Sputum samples were decontaminated according to the sodium
hydroxide–N-acetyl-L-cysteine method.21 An aliquot was used for
microscopical examination of auramine-stained sputum smears, and the
remainder was used for parallel Löwenstein–Jensen
culture, automated mycobacterial culture, and MODS culture (see Fig. I in
the Supplementary Appendix, available with the full text of this article at
www.nejm.org). Löwenstein–Jensen culture
and automated mycobacterial culture with the use of the MBBacT system
(bioMérieux) were selected because they are reference methods
commonly used in developing and industrialized countries, respectively.
After inoculation of 250 μl of decontaminant,
Löwenstein–Jensen slants were incubated at
37°C and examined twice weekly from day 7 through day 60.21 MBBacT bottles were inoculated with
500 μl of decontaminant, and cultures were monitored
continuously for 42 days according to the recommendations of the
manufacturer.
The MODS assay was performed as described previously.6 (link),7 (link)
Briefly, broth cultures were prepared in 24-well tissue-culture plates
(Becton Dickinson), each containing 720 μl of decontaminant,
Middlebrook 7H9 broth (Becton Dickinson), oxalic acid, albumin, dextrose,
and catalase (OADC) (Becton Dickinson), and polymyxin, amphotericin B,
nalidixic acid, trimethoprim, and azlocillin (PANTA) (Becton Dickinson). For
each sample, 12 wells were used: in 4 control wells, no drug was added, and
each of the remaining 8 wells contained one of four drugs at one of two
concentrations tested. The cultures were examined under an inverted light
microscope at a magnification of 40× every day (except Saturday
and Sunday) from day 4 to day 15, on alternate days from day 16 to day 25,
and twice weekly from day 26 to day 40. To minimize cross-contamination and
occupational exposure, plates were permanently sealed inside plastic ziplock
bags after inoculation and were subsequently examined within the bag.
Positive cultures were identified by cord formation, characteristic of
M. tuberculosis growth, in liquid medium in drug-free
control wells, as described previously.6 (link),7 (link),22 (link) Nontuberculous mycobacteria were recognized by
their lack of cording or, for M. chelonae (which is the
only nontuberculous mycobacteria that does form cords), by rapid overgrowth
by day 5. Fungal or bacterial contamination was recognized by rapid
overgrowth and clouding in wells.
If contamination was detected, the original sample was cultured
again after being decontaminated once more. Spacer oligonucleotide typing
(spoligotyping), polymerase chain reaction with multiple primers,23 (link) or both were applied to all isolates
from each of the three types of cultures in order to confirm the presence of
M. tuberculosis.
Publication 2006
Acetylcysteine Albumins Amphotericin B Auramine O Azlocillin Bacteria Biological Assay Catalase Cone-Rod Dystrophy 2 Glucose Light Microscopy Multiple Organ Failure Mycobacterium Nalidixic Acid Nontuberculous Mycobacteria Oligonucleotide Primers Oligonucleotides Oxalic Acids Pharmaceutical Preparations Polymerase Chain Reaction Polymyxins Sputum Tissues Trimethoprim Tuberculosis Vaccination

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2011
Adult Cough Ethics Committees, Research Microscopy Nontuberculous Mycobacteria Patients Population Group Primary Health Care Sputum Susceptibility, Disease Tuberculosis Tuberculosis, Multidrug-Resistant
Raw read data for 8,136 strains were downloaded from the SRA (see SRA accessions in Supplementary Table 1). Reads were mapped onto a reference strain of H37Rv (GenBank accession number CP003248.2) using BWA version 0.7.1068 (link). Variants were identified using Pilon version 1.11 as described 67 (link). The global M. tuberculosis lineage designations used in our analysis, as well as each strain’s spoligotype, were predicted using digital spoligotyping as in Cohen et al., 20156 .
We eliminated 824 strains that did not pass our quality control filters: average sequencing depth of coverage >20X; fraction of long insertions <0.2; ambiguity rate <0.5 (to remove samples that were suspected to represent mixes of different genotypes); number of low coverage bases <250,000; and having a single match to one lineage in our lineage-prediction algorithm. We also eliminated strains for which Pilon failed three times. Of the remaining 7,312 samples, we removed 1,970 strains with no “country” metadata or description in a publication; 19 strains with substantial non-tuberculous mycobacteria contamination; as well as 13 additional duplicate patient samples. These filters resulted in a final set of 5,310 strains for analysis.
Emu69 was run to canonicalize variants. We conducted phylogenetic analyses for the entire set of 5,310 strains, as well as for a subset corresponding to each lineage and each United Nations geographical subregion23 with >30 strains (Supplementary Table 3). For each set, all sites with unambiguous single nucleotide polymorphisms (SNPs) in at least one strain were combined into a concatenated alignment. Ambiguous positions were treated as missing data. The concatenated alignment was then were used to generate a midpoint rooted phylogenetic tree using FastTree70 (link) version 2.1.8.
Publication 2017
Fingers Genotype Insertion Mutation Mycobacterium tuberculosis Nontuberculous Mycobacteria Patients Single Nucleotide Polymorphism Strains
Patients were divided into four categories for analysis: those with smear- and culture-positive pulmonary tuberculosis; those with smear-negative, culture-positive pulmonary tuberculosis; those with no bacteriologic evidence of tuberculosis who had improvement without treatment (no tuberculosis); and those who were smear- and culture-negative for pulmonary tuberculosis who nonetheless were treated for tuberculosis on the basis of clinical and radiologic findings (clinical tuberculosis). A smear-positive case was defined as at least two smears of scanty grade (1 to 10 acid-fast bacilli per 100 fields) or one or more smears of 1+ or more (10 to 99 bacilli per 100 fields). A culture-positive case was defined as positive results on at least one of four culture vials. Because a clear final diagnosis was required, patients with an indeterminate diagnosis were excluded from the main analysis if there was a negative culture result while the patient was receiving tuberculosis treatment (for patients with suspected multidrug resistance), contamination of at least three of four cultures, growth of nontuberculous mycobacteria only, indeterminate phenotypic rifampin susceptibility, a negative culture with a positive sputum smear, or suspected cross-contamination of cultures (i.e., only one of four cultures had positive results after >28 days to growth in MGIT or <20 colonies in Löwenstein–Jensen medium) or if the patient died or was lost to follow-up.
Publication 2010
Bacillus acidicola Diagnosis Lacticaseibacillus casei Multi-Drug Resistance Nontuberculous Mycobacteria Patients Phenotype Rifampin Sputum Susceptibility, Disease Tuberculosis Tuberculosis, Pulmonary
We defined a TB patient as any person living with HIV and at least one specimen culture positive for Mycobacterium tuberculosis (MTB). We defined participants as having no TB if cultures were negative for MTB and participants were judged not to have TB on the basis of the original study definition of the investigators. We excluded from the analysis: (1) patients who were receiving treatment for TB (infection or disease) at enrolment; (2) patients who were AFB smear positive, but whose culture grew non-tuberculous mycobacteria; and (3) patients who were AFB smear positive or scanty, but sputum culture negative.
Full text: Click here
Publication 2011
Infection Mycobacterium tuberculosis Nontuberculous Mycobacteria Patients Sputum

Most recents protocols related to «Nontuberculous Mycobacteria»

Cases were defined in two ways: 1) All cultures with MTB-positive results (regardless of Xpert Ultra results), or 2) (a) Xpert Ultra positive (excluding trace), and (b) culture not TB (i.e., culture-negative, nontuberculous mycobacteria, contaminated, or not done), and (c) CXR suggestive of active TB as determined by three central readers, and (d) no history of TB (past or current).
Full text: Click here
Publication 2023
Nontuberculous Mycobacteria
The diagnostic material was pre-treated with N-acetyl-l-cysteine in combination with 1% NaOH (NALC–NaOH) and inoculated into Loewenstein–Jensen (LJ) and Finn II egg-based media as recommended in previous works [29 ,30 ,31 ]. Primary identification of mycobacteria was carried out based on visual registration of the culture’s growth (not earlier than 3–4 weeks of incubation) and its features (colonies of characteristic morphology and color). The primary identification of strains included microscopic confirmation of the Ziehl–Neelsen-stained bacteria and assessment of the cord factor.
An immunochromatographic test was used to detect a fraction of the mycobacterial protein MPT64, which is isolated from MBT cells during cultivation on liquid and solid nutrient media [25 (link)]. SD BIOLINE TB Ag MPT64 Rapid tests (Standard Diagnostics, Korea) were used for identification. The test was applied to both samples cultured on solid and liquid nutrient media. The presence of two colored bands “T” and “C” in the result window indicated a positive result.
To differentiate individual species within the M. tuberculosis complex, we used the main biochemical tests to determine nicotinic acid and nitrate reductase, and an additional test for colony growth on nutrient media containing thiophene-2-carboxylic acid hydrazide (2 μg/mL). Unlike M. tuberculosis, only M. bovis is sensitive to low concentrations of thiophene-2-carboxylic acid hydrazide and is characterized by negative results of biochemical tests. No M. bovis isolates were detected in this study.
To differentiate M. tuberculosis from non-tuberculous acid-fast mycobacteria, the following basic biochemical tests were used: nitrate reductase test, thermostable catalase test, salicylic sodium test, and niacin test. We additionally assessed the growth on nutrient media containing Tween 80 and thiophene-2-carboxylic acid hydrazide.
Full text: Click here
Publication 2023
Acetylcysteine Acids Bacteria Catalase Cells Cord Factors Culture Media Diagnosis Immunochromatography Microscopy MPB64 protein, Mycobacterium Mycobacterium Mycobacterium tuberculosis Niacin Nicotinic Acids Nitrate Reductase Nontuberculous Mycobacteria Nutrients Salicylic Acid Sodium Strains Test, Quick thiophene-2-carboxylic acid hydrazide Tween 80
A 60-year-old Thai male presented with a 3-month history of a low-grade fever with chronic nonproductive cough, generalized lymphadenopathy, and weight loss (7 kg in 3 months). Two weeks before admission to Srinagarind Hospital, the patient developed multiple discrete erythematous papules and pustules on both extremities. A cervical lymph node biopsy was performed. The histopathological result was consistent with reactive paracortical hyperplasia. The tissue cultures for mycobacteria and fungus were negative. The PCR test was positive for nontuberculous mycobacteria, but the species could not be identified. A skin biopsy was performed, and the histopathological result was consistent with subcorneal spongioform pustulosis. The anti-HIV test was negative, but the anti-interferon-γ autoantibodies test was positive at 1:200,000. The patient was diagnosed with disseminated nontuberculous mycobacteria infection with adult-onset immunodeficiency due to the anti-interferon-γ autoantibodies with pustular eruption. Anti-mycobacterial therapy with clarithromycin (1000 mg/day) and moxifloxacin (400 mg/day), and prednisolone (30 mg/day with a decreasing dose of 10 mg every two weeks) was started. The patient’s symptoms and skin lesions improved after the treatment; however, the patient developed a flare-up of disease and pustular lesions. Acitretin was added to control the lesions.
Full text: Click here
Publication 2023
Acitretin Adult Autoantibodies Biopsy Clarithromycin Cough Erythema Exanthema Fever Fungi Hyperplasia Immunologic Deficiency Syndromes Interferon Type II Lymphadenopathy Males Moxifloxacin Mycobacterium Mycobacterium Infections, Nontuberculous Neck Nodes, Lymph Nontuberculous Mycobacteria Patients Prednisolone Skin Testing, HIV Thai Tissues
Data for all notified PTB cases among students in Zhejiang Province were collected in the Tuberculosis Information Management System (TBIMS) from January 2007 to December 2020. We excluded extrapulmonary TB cases and cases identified as nontuberculous mycobacteria (17 (link)). All students included kindergartens, primary schools, high schools, and universities (18 (link)). Details for each PTB case included basic demographic information, clinical diagnosis information, laboratory outcomes, and treatment outcomes. Annual student population data for each administrative district were obtained from the Zhejiang Statistical Yearbook, education administrative department and Local Statistical Yearbook.
Full text: Click here
Publication 2023
Diagnosis Nontuberculous Mycobacteria Student Tuberculosis Tuberculosis, Extrapulmonary
As the first case was identified, we analyzed water and aerosols from our two Stockert 3T HCD units. M. chimaera was isolated from both samples. Based on the recommendations of the Swiss Chimaera Task Force, we replaced the two units and built a dedicated space outside the operating room to store and control the HCD remotely [18 ]. We also established a strict weekly chlorine-based disinfection protocol of the HCD water circuits, according to the manufacturer’s instructions, as well as a monthly analysis for the atypical mycobacteria of HCD water and air samples.
Full text: Click here
Publication 2023
Aerosols Chimera Chlorine Disinfection Nontuberculous Mycobacteria

Top products related to «Nontuberculous Mycobacteria»

Sourced in United States, Germany
The Xpert MTB/RIF is a molecular diagnostic test developed by Cepheid. It is designed to detect the presence of Mycobacterium tuberculosis (MTB) and identify resistance to the antibiotic rifampicin (RIF) directly from sputum samples. The test utilizes real-time PCR technology to provide rapid and accurate results.
Sourced in United States, Spain, Switzerland, Italy
The Cobas Amplicor is a compact, automated instrument designed for nucleic acid testing. It is used for the detection and quantification of targeted nucleic acid sequences in clinical samples. The Cobas Amplicor provides reliable and consistent results through its automated processing and analysis capabilities.
Sourced in United States
The MGIT 960 system is a fully automated, high-throughput diagnostic instrument designed for the detection and identification of mycobacteria from clinical specimens. The system utilizes fluorescent technology to monitor the growth of mycobacteria in liquid culture, providing a rapid and efficient method for the diagnosis of tuberculosis and other mycobacterial infections.
Sourced in Germany
The GenoType MTBC is a molecular diagnostic test designed to identify and differentiate members of the Mycobacterium tuberculosis complex (MTBC) from other mycobacterial species. The test utilizes DNA-based technology to provide accurate and reliable identification of MTBC organisms.
Sourced in United States, Germany
The BACTEC MGIT 960 is a fully automated mycobacterial detection system that utilizes liquid culture technology to facilitate the rapid detection of mycobacteria, including Mycobacterium tuberculosis, in clinical specimens. The system employs fluorescence-based technology to continuously monitor the growth of mycobacteria in culture tubes, providing timely and accurate results.
Sourced in Germany
The GenoType Mycobacterium CM/AS is a lab equipment product used for the identification of Mycobacterium species. It is designed to detect and differentiate between Mycobacterium complex and Mycobacterium avium-intracellulare complex.
Sourced in United States
The BACTEC 960 Mycobacterial Growth Indicator Tube is a lab equipment product that functions as a detection system for the growth of mycobacteria. It provides a standardized method for the cultivation and detection of mycobacteria in clinical samples.
Sourced in United States, Cameroon, China, Germany
The BACTEC MGIT 960 system is a fully automated mycobacterial growth indicator tube (MGIT) system designed for the detection and identification of mycobacteria in clinical specimens. The system utilizes fluorescent technology to continuously monitor for bacterial growth in liquid culture media.
Sourced in Germany
The GenoType Mycobacterium CM/AS assay is a molecular diagnostic tool used for the identification of mycobacterial species. It is designed to detect and differentiate between the Mycobacterium complex and Mycobacterium avium-Mycobacterium intracellulare complex from clinical specimens.

More about "Nontuberculous Mycobacteria"

Nontuberculous Mycobacteria (NTM) are a group of environmental bacteria that can cause serious infections, distinct from Tuberculosis (TB).
These mycobacteria, also known as atypical mycobacteria or environmental mycobacteria, are ubiquitous in soil, water, and other natural settings.
NTM infections can be difficult to diagnose and treat, as they often require specialized testing methods and prolonged antimicrobial therapies.
Some key diagnostic tools for NTM include the Xpert MTB/RIF assay, which can differentiate NTM from Mycobacterium tuberculosis, and the Cobas Amplicor system, which can identify various NTM species.
The MGIT 960 system and BACTEC MGIT 960 are automated liquid culture systems used to detect the growth of NTM and other mycobacteria.
The GenoType MTBC and GenoType Mycobacterium CM/AS assays are molecular tests that can further speciate NTM isolates.
Effective treatment of NTM infections often requires a combination of multiple antibiotics, such as macrolides, rifamycins, and ethambutol, administered over an extended period.
Researchers are continually working to develop more accurate diagnostic methods and optimize treatment protocols to improve outcomes for individuals affected by these challenging mycobacterial infections.
PubCompare.ai is a valuable tool that helps researchers streamline their NTM studies by surfacing the most effective research methods and products from the published literature, preprints, and patents.
Its AI-driven comparisons enhance the reproducibility and accuracy of NTM research, enabling scientists to identify the most reliable and effective approaches for their investigations.